0001209191-20-043323.txt : 20200722 0001209191-20-043323.hdr.sgml : 20200722 20200722170320 ACCESSION NUMBER: 0001209191-20-043323 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200720 FILED AS OF DATE: 20200722 DATE AS OF CHANGE: 20200722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huang James CENTRAL INDEX KEY: 0001573160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33038 FILM NUMBER: 201041990 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE STREET 2: SUITE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZIOPHARM ONCOLOGY INC CENTRAL INDEX KEY: 0001107421 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841475642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE FIRST AVENUE STREET 2: PARRIS BUILDING 34, NAVY YARD PLAZA CITY: BOSTON STATE: MA ZIP: 02129 BUSINESS PHONE: 617-259-1970 MAIL ADDRESS: STREET 1: ONE FIRST AVENUE STREET 2: PARRIS BUILDING 34, NAVY YARD PLAZA CITY: BOSTON STATE: MA ZIP: 02129 FORMER COMPANY: FORMER CONFORMED NAME: EASYWEB INC DATE OF NAME CHANGE: 20010213 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-20 0 0001107421 ZIOPHARM ONCOLOGY INC ZIOP 0001573160 Huang James C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BUILDING 34 BOSTON MA 02129 1 0 0 0 Stock Option (right to buy) 3.43 2020-07-20 4 A 0 119178 0.00 A 2030-07-20 Common Stock 119178 119178 D The shares underlying this option will vest on July 20, 2022. /s/ Robert Hadfield, Attorney-in-Fact 2020-07-22